$11.67
-0.79 (-6.34%)
Open$12.60
Previous Close$12.46
Day High$13.00
Day Low$11.03
52W High$21.41
52W Low$7.20
Volume—
Avg Volume598.8K
Market Cap102.06M
P/E Ratio—
EPS$-0.88
SectorBiotechnology
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 2.06M | 8.74M | 7.84M |
| Net Income | -17,995,573 | -2,031,310 | -1,359,886 |
| Profit Margin | -874.3% | -23.2% | -17.3% |
| EBITDA | -18,585,812 | -2,389,064 | -2,398,436 |
| Free Cash Flow | — | -1,186,852 | -1,098,506 |
| Rev Growth | — | +14.6% | -0.2% |
| Debt/Equity | 0.02 | 0.28 | 0.25 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $251.64 | -1.05% | 118.2 | 429.58B |
| AMGN | Amgen Inc | $362.12 | +0.44% | 24.8 | 193.10B |
| GILD | Gilead Sciences Inc | $126.34 | +0.01% | 17.1 | 157.21B |
| VRTX | Vertex Pharmaceuticals Inc | $496.73 | -0.58% | 28.1 | 121.87B |
| REGN | Regeneron Pharmaceuticals | $623.54 | -1.31% | 15.0 | 66.35B |
| ALNY | Alnylam Pharmaceuticals Inc | $301.03 | +2.56% | 69.3 | 39.97B |